The Imperial College Healthcare NHS Trust neuro-oncology unit at Charing Cross Hospital cares for patients with brain and spinal tumours from North-West London and beyond. We are one of the 17 Tessa Jowell Centres of Excellence across the UK providing excellence in patient treatment, care and research Our catchment area extends to Windsor and further north to Luton and Watford, but we attract referrals from around the country, especially for glioma, skull-base and pituitary work. 
We are one of only two centres in London offering comprehensive brain tumour diagnosis and treatment from one location, and part of the Imperial Academic Health Science Network. Our strong connections with Imperial College London allow us to be at the forefront of cutting-edge brain tumour research especially with our collaborations with the Translational Brain Tumour Group (TBTG) lab, computational oncology group, John Fulcher lab and Brain Tumour Research Centre of Excellence. 

Conditions and treatments

We treat brain and spinal tumours, including glioblastoma, high and low grade gliomas, ependymoma, medulloblastoma, meningioma, pituitary and skull base tumours, as well as cranial and spinal metastases. 

The management of brain and spinal tumours requires a complex, multidisciplinary approach, involving the use of surgery, radiotherapy and chemotherapy where appropriate. We offer imaging, surgery, radiotherapy, chemotherapy, rehabilitation, psychosocial support and palliative care. 

We also have significant experience in introducing novel therapies. We host the joint Imperial/ICHT Neuro-oncology Advanced Therapies Group, as well as the UK’s only Optune support group. 

Further online resources